Researchers from Geneseeq and a network of Chinese academic hospitals have validated a blood test that can detect a broad ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Novartis has presented new data from the Phase III NATALEE trial at ASCO 2025, showcasing Kisqali’s ability to reduce the risk of recurrence in ...

(EBC) patients receiving Kisqali in 1-year post-treatment analysis 1 Tolerability remained consistent, with fewer treatment discontinuations due to adverse events among pre-menopausal patients 1 ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

Reflex blood-based multi-cancer early detection (MCED) test demonstrated clinically meaningful per-cancer Positive Predictive Value (PPV) and early-stage sensitivity for multiple cancers with elevated ...

About the expert Laura Dean, MD, is a board-certified diagnostic radiologist at Cleveland Clinic, where she has been practicing since 2014. She completed her residency at Northwestern University’s ...

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or ...

GE HealthCare (Nasdaq: GEHC) today announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®) for ...